Health CanadaGeneral Alert
Archived – Possible Association of RITUXAN (Rituximab) with Hepatitis B Reactivation – Hoffmann-La Roche Limited
Published: July 30, 2004Recall ID: 24527Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
Archived – Possible Association of RITUXAN (Rituximab) with Hepatitis B Reactivation – Hoffmann-La Roche Limited
Recalling Firm: Marketed health products
Reason for Recall / Hazard
Product safety
Product Description & Identification
Archived – Possible Association of RITUXAN (Rituximab) with Hepatitis B Reactivation – Hoffmann-La Roche Limited
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24527 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/archived-possible-association-rituxan-rituximab-hepatitis-b-reactivation-hoffmann |
| Issue | Product safety |
| Title | Archived – Possible Association of RITUXAN (Rituximab) with Hepatitis B Reactivation – Hoffmann-La Roche Limited |
| Archived | 1 |
| Category | Biologic or vaccine |
| Last updated | 2004-07-30 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - Archived – Possible Association of RITUXAN (Rituximab) with Hepatitis B Reactivation – Hoffmann-La Roche Limited Check if your household is affected: https://therecallfile.com/recalls/archived-possible-association-of-rituxan-rituximab-with-hepatitis-b-re/CANADA-24527
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordArchived – Possible Association of RITUXAN (Rituximab) with Hepatitis B Reactivation – Hoffmann-La Roche Limited